You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. PREFAB MODULAR LIQUID-COOLED MICRO DATA CENTER

    SBC: Flexnode Inc            Topic: 1

    "To enable the future needs of efficient computing for edge data centers, Flexnode and its partners, the University of Maryland (UMD), Boeing, Iceotope, SHoP Architects, and Arup, propose to develop a prefabricated modular micro data center with unprecedented energy efficiency and power density. The proposed system leverages four key component and system-level technology advancements: (a) a novel, ...

    STTR Phase I 2024 Department of EnergyARPA-E
  2. PREFAB MODULAR LIQUID-COOLED MICRO DATA CENTER

    SBC: Flexnode Inc            Topic: 1

    "To enable the future needs of efficient computing for edge data centers, Flexnode and its partners, the University of Maryland (UMD), Boeing, Iceotope, SHoP Architects, and Arup, propose to develop a prefabricated modular micro data center with unprecedented energy efficiency and power density. The proposed system leverages four key component and system-level technology advancements: (a) a novel, ...

    STTR Phase II 2024 Department of EnergyARPA-E
  3. PREFAB MODULAR LIQUID-COOLED MICRO DATA CENTER

    SBC: Flexnode Inc            Topic: 1

    "To enable the future needs of efficient computing for edge data centers, Flexnode and its partners, the University of Maryland (UMD), Boeing, Iceotope, SHoP Architects, and Arup, propose to develop a prefabricated modular micro data center with unprecedented energy efficiency and power density. The proposed system leverages four key component and system-level technology advancements: (a) a novel, ...

    STTR Phase II 2024 Department of EnergyARPA-E
  4. STTR Phase I:Hyper Transfer Vehicle Concept Demonstration

    SBC: VORTEX SPACE SYSTEMS, LLC            Topic: SP

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) project is to develop a new, non-rocket based thrust technology capable of removing debris from space. This project will provide two separate business models including hardware fabrication and testing, and active orbital debris removal services. Six Department of Defense (DoD) and National Oceanic Atmospheric ...

    STTR Phase I 2023 National Science Foundation
  5. STTR Phase I:Novel Medical Equipment Utilization Tracking System for Improved Patient Safety and Hospital Efficiency

    SBC: OPAL HTM INC            Topic: I

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project relates to the development of a novel system capable of measuring medical equipment utilization with high accuracy and scalability. This innovation will arm healthcare technology managers with the insights needed to optimize inventory size and composition according to actual patient needs, the ...

    STTR Phase I 2023 National Science Foundation
  6. An Improved PCV-2 Vaccine

    SBC: BIOLOGICAL MIMETICS, INC.            Topic: 83

    Current PCV2 vaccines stimulate protective immunity to PCV2a and 2b serotypes but reducedprotection against evolving and emerging strains such as PCV2d 2g and 2h. We propose to useImmune Refocusing Technology (IRT) to reduce the immunogenicity of epitopes that stimulatesubtype-restricted immunity and refocus towards more broadly protective epitopes. Our first- generation IRT candidate demonstrated ...

    STTR Phase I 2023 Department of Agriculture
  7. Targeted ColQ gene therapy for Congenital Myasthenic Syndromes

    SBC: Amplo Biotechnology, Inc.            Topic: 106

    PROJECT SUMMARY Congenital Myasthenic Syndromes (CMS) are a group of clinically similar neuromuscular transmission disorders that differ in their underlying genetic mutation. While some phenotypical variation exists, CMS are commonly characterized by muscle weakness (myasthenia) that worsens with physical exertion. Defects in Collagen Q (ColQ), a multidomain functional protein of the Neuro Muscula ...

    STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  8. Inducible HMGB1 antagonist for viral-induced acute lung injury.

    SBC: SIGMOVIR BIOSYSTEMS, INC.            Topic: NHLBI

    For more than a decade, our work has focused on development of therapeutic interventions for viral- and bacterial-induced acute lung injury (ALI) and the more severe acute respiratory distress syndrome (ARDS). Significantly, we identified the Toll-like receptor 4 (TLR4) signaling pathway as key to the host response to influenza and secondary bacterial infection following influenza. We also identif ...

    STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  9. Development of a portable beat-to-beat fetal ECG system

    SBC: AUSCULTECH DX LLC            Topic: NICHD

    Project Summary There are 24,000 stillbirths per year in the United States, and 2.6 million stillbirths per year worldwide, with no significant decrease in the last decade. Abnormal fetal heart rhythms, such as long QT syndrome, are thought to play an important role in these deaths, and may cause 3- 10% of unexplained stillbirths. This is in addition to known fetal arrhythmias, which affect 1-3% o ...

    STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  10. An immunotherapeutic IgY formulation against norovirus diarrhea

    SBC: SCALED MICROBIOMICS LLC            Topic: NIAID

    Project Summary/Abstract for STTR Phase I Application: An immunotherapeutic IgY formulation against norovirus diarrhea Human norovirus (HuNoV) infects millions of people globally each year, causing diarrheal illness resulting in more than 200,000 deaths annually, particularly in the very young, the very old, and the immunocompromised. There is currently neither an effective vaccine nor effective t ...

    STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government